4//SEC Filing
Salvadori Daniel Gesua Sive 4
Accession 0001415889-23-003060
CIK 0000001800other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 7:18 PM ET
Size
7.4 KB
Accession
0001415889-23-003060
Insider Transaction Report
Form 4
Salvadori Daniel Gesua Sive
Senior Vice President
Transactions
- Award
Common shares without par value
2023-02-17+17,700→ 129,948 total - Award
Option (right to buy)
2023-02-17+69,803→ 69,803 totalExercise: $106.24From: 2024-02-17Exp: 2033-02-16→ Common Shares (69,803 underlying)
Footnotes (2)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 23,267 on February 17, 2024, 23,268 on February 17, 2025, and 23,268 on February 17, 2026.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001620564
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 7:18 PM ET
- Size
- 7.4 KB